Table 3.
High-risk exposure | Patients | Controls | Adjusted OR (95 % CI)a | p-Valueb | ||
---|---|---|---|---|---|---|
Genotype | Ile/Ile | Ile /Val | Ile/Ile | Ile /Val | ||
Parity | ||||||
Ever | 370 | 35 | 416 | 23 | 1.739 (1.006–3.009) | 0.0472 |
Never | 45 | 6 | 50 | 6 | 1.596 (0.441–5.773) | 0.4709 |
Oral contraceptive use | ||||||
Ever | 187 | 21 | 205 | 12 | 1.923 (0.918–4,030) | 0.0821 |
Never | 228 | 20 | 261 | 17 | 1.370 (0.697–2.692) | 0.3597 |
Smoking | ||||||
Ever | 134 | 27 | 154 | 10 | 2.978 (1.382–6.418) | 0.0052 |
Never | 281 | 14 | 312 | 19 | 1.338 (0.575–3.113) | 0.4983 |
Menopausal status | ||||||
Premenopausal | 149 | 10 | 178 | 12 | 0.939 (0.391–2.257) | 0.8885 |
Postmenopausal | 266 | 31 | 288 | 17 | 1.857 (0.997–3.460) | 0.0507 |
a(Ile /Val vs. Ile/Ile)
bChi square analysis
All p-values were adjusted by age. Significant results are highlighted in bold font
CI confidence interval, OR odds ratio